Axel Hinke - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

All papers authored by Axel Hinke

This paper was not found in any repository, but could be made available legally by the author.

2021 Richard Adams

ORCID

, Kaitlyn Goey, Benoist Chibaudel

ORCID

, Miriam Koopman, Cornelis Punt, Dirk Arnold, Axel Hinke

ORCID

, Susanna Hegewisch-Becker, Aimery de Gramont, Roberto Labianca, Eduardo Diaz Rubio, Kjell Magne Tveit, Harpreet Wasan, Richard Kaplan, Louise Brown and 2 other authors

Treatment breaks in first line treatment of advanced colorectal cancer: An individual patient data meta-analysis

Upload

This paper was not found in any repository, but could be made available legally by the author.

2018 Susanna Hegewisch-Becker, Stefanie Nöpel-Dünnebacke, Axel Hinke

ORCID

, Ullrich Graeven, Anke Reinacher-Schick, Jan Hertel, Christian A. Lerchenmüller, Birgitta Killing, Reinhard Depenbusch, Salah-Eddin Al-Batran, Thoralf Lange, Georg Dietrich, Andrea Tannapfel, Dirk Arnold

Impact of primary tumour location and RAS/BRAF mutational status in metastatic colorectal cancer treated with first-line regimens containing oxaliplatin and bevacizumab: Prognostic factors from the AIO KRK0207 first-line and maintenance therapy trial

Upload

This paper was not found in any repository, but could be made available legally by the author.

Stefanie Noepel-Duennebacke, Dirk Arnold, Jan Hertel, Andrea Tannapfel, Axel Hinke

ORCID

, Susanna Hegewisch-Becker, Anke Reinacher-Schick

Impact of the Localization of the Primary Tumor and RAS/BRAF Mutational Status on Maintenance Strategies After First-line Oxaliplatin, Fluoropyrimidine, and Bevacizumab in Metastatic Colorectal Cancer: Results From the AIO 0207 Trial

Upload

This paper is made freely available by the publisher.

Peter Dall, Thorsten Koch, Thomas Göhler, Johannes Selbach, Andreas Ammon, Jochen Eggert, Nidal Gazawi, Daniela Rezek, Arthur Wischnik, Carsten Hielscher, Nicolas Schleif, Ursula Cirrincione, Axel Hinke

ORCID

, Gabriele Feisel-Schwickardi

Trastuzumab without chemotherapy in the adjuvant treatment of breast cancer: subgroup results from a large observational study

Download from doi.org

Missing publications? Search for publications with a matching author name.